|
 |
J Clin Outcomes Manage
2006 Apr;13(4):235-246
The abnormal pap test evaluation, treatment, and monitoring
Moore KN, Walker JL
Educational Needs Addressed Over 10,000 new cases of cervical cancer and nearly 4000 cervical cancer–related deaths occurred in the United States last year. Detection of cervical cancer in its earliest stages is lifesaving, and efforts are needed to improve low levels of compliance with screening guidelines. New technology for performing cervical cytology has evolved, as have recommendations for classifying and interpreting results. Major developments include revision of the Bethesda System terminology, the approval of a human papillomavirus DNA test, the release of evidence-based consensus guidelines for managing abnormal Pap tests, and the im-pending availability of HPV type–specific testing. Physicians need to be familiar with these developments and use the best available evidence for cervical cancer screening and treatment of women with abnormal Pap tests. Educational Objectives After participating in this CME activity, primary care physicians should be able to 1. Understand the use of the Bethesda System terminology for reporting Pap test results 2. Know the recommended guidelines for timing and method of cervical cancer screening 3. Describe approaches to improving screening rates 4. Describe the management options for women with abnormal cervical cytology results
Case-Based Review, CME
Search the Turner White index to find abstracts of articles published in JCOM.
|
